The Global Psoriasis Atlas

The Global Psoriasis Atlas is the leading epidemiological resource on psoriasis globally; thus informing research, policy and health care provision worldwide.

Partners

In cooperation within the ILDS Project Grand Challenges of Global Skin Health IFPA, ILDS and IPC have agreed to cooperate within this area of mutual interest to increase the understanding of the global burden of psoriasis, through the development of a Global Psoriasis Atlas based on existing data and future studies.

How can you support the GPA?

Establishing a sustainable high quality GPA requires the support of industry, organisations with relevant datasets and collaboration across regions and countries.
If you or your organisation is interested in contributing to the development of the GPA via monetary or in-kind contributions, or wish to undertake research relevant to the GPA, please contact the GPA Programme Manager, Rebekah Swan.

GPA Annual Report (April 2017 - March 2018)

Supporters

The Global Psoriasis Atlas is supported by grants from LEO Foundation and Novartis Pharma AG and is sponsored by AbbVie and Eli Lilly UK and Company Limited.

Other supporters

abbvie_logo_GPA
Lilly-Logo_GPA
Novartis-Logo_GPA